Suppr超能文献

在给予右美托咪定期间,咪唑啉1受体激活可维持自主呼吸新生大鼠的呼吸驱动力。

Imidazoline 1 receptor activation preserves respiratory drive in spontaneously breathing newborn rats during dexmedetomidine administration.

作者信息

Sato Nana, Saiki Chikako, Tamiya Junko, Imai Toshio, Sunada Katsuhisa

机构信息

Department of Dental Anesthesiology, School of Life Dentistry at Tokyo, The Nippon Dental University, Tokyo, Japan.

Department of Physiology, School of Life Dentistry at Tokyo, The Nippon Dental University, Tokyo, Japan.

出版信息

Paediatr Anaesth. 2017 May;27(5):506-515. doi: 10.1111/pan.13107. Epub 2017 Feb 8.

Abstract

BACKGROUND

Dexmedetomidine is an alpha-2 (α ) adrenoceptor and imidazoline 1 (I ) receptor agonist that provides sedation without loss of respiratory drive.

AIMS

The aim of this study was to elucidate the involvement of α -adrenoceptor and I receptor in the cardiorespiratory changes induced by dexmedetomidine in spontaneously breathing newborn rats.

METHODS

An abdominal catheter to administer drugs and three subcutaneous electrodes to record electrocardiographic data were inserted into 2- to 5-day-old Wistar rats under isoflurane anesthesia. In individual chambers, each rat was intraperitoneally administered dexmedetomidine (50 μg·kg ) followed 5 min later by normal saline or 1, 5, or 10 mg·kg atipamezole (selective α -adrenoceptor antagonist) or efaroxan (α -adrenoceptor/I receptor antagonist). Cardiorespiratory indices were recorded before and after drug administration.

RESULTS

The administration of dexmedetomidine alone resulted in significant changes to most of the cardiorespiratory indices examined. The addition of 5 or 10 mg·kg atipamezole or 1 mg·kg efaroxan completely ameliorated the dexmedetomidine-associated reduction in heart rate (HR). The addition of 1 mg·kg atipamezole or 1 or 5 mg·kg efaroxan completely ameliorated the dexmedetomidine-associated reduction in respiratory frequency. Mean inspiratory flow (V /T ; V is tidal volume and T is inspiratory time), which is an index of respiratory drive, was not significantly affected by the administration of dexmedetomidine alone (P = 0.273) or dexmedetomidine + atipamezole (P = 0.605, 0.153, 0.138 for 1, 5, 10 mg·kg atipamezole, respectively); however, it was significantly decreased after the administration of dexmedetomidine + efaroxan (P = 0.029, <0.001, <0.001 for 1, 5, 10 mg·kg efaroxan, respectively).

CONCLUSIONS

Our results suggest that in newborn rats undergoing dexmedetomidine sedation, the α -adrenoceptor, but not I receptor, is involved in the regulation of HR and respiratory frequency, and that activation of the I receptor plays a major role in the maintenance of respiratory drive.

摘要

背景

右美托咪定是一种α2(α)肾上腺素能受体和咪唑啉1(I)受体激动剂,可提供镇静作用而不影响呼吸驱动。

目的

本研究旨在阐明α肾上腺素能受体和I受体在右美托咪定诱导的自主呼吸新生大鼠心肺变化中的作用。

方法

在异氟烷麻醉下,将一根用于给药的腹腔导管和三根用于记录心电图数据的皮下电极插入2至5日龄的Wistar大鼠体内。在单独的实验箱中,每只大鼠腹腔注射右美托咪定(50μg·kg),5分钟后再腹腔注射生理盐水或1、5或10mg·kg的阿替美唑(选择性α肾上腺素能受体拮抗剂)或依酚氯铵(α肾上腺素能受体/I受体拮抗剂)。在给药前后记录心肺指标。

结果

单独注射右美托咪定导致所检测的大多数心肺指标发生显著变化。添加5或10mg·kg的阿替美唑或1mg·kg的依酚氯铵可完全改善右美托咪定引起的心率(HR)降低。添加1mg·kg的阿替美唑或1或5mg·kg的依酚氯铵可完全改善右美托咪定引起的呼吸频率降低。平均吸气流量(V/T;V为潮气量,T为吸气时间),作为呼吸驱动的指标,单独注射右美托咪定(P = 0.273)或右美托咪定+阿替美唑(分别为1、5、10mg·kg阿替美唑时,P = 0.605、0.153、0.138)对其无显著影响;然而,注射右美托咪定+依酚氯铵后其显著降低(分别为1、5、10mg·kg依酚氯铵时,P = 0.029、<0.001、<0.001)。

结论

我们的结果表明,在接受右美托咪定镇静的新生大鼠中,α肾上腺素能受体而非I受体参与心率和呼吸频率的调节,且I受体的激活在维持呼吸驱动中起主要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验